A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We present a benchtop protocol to induce thrombosis in ventricular assist devices (VAD) within a recirculating test platform. This method serves to identify thrombogenic hotspots in the blood flow path and can help improve thromboresistance ahead of preclinical testing in animal models.

Abstract

The risk of thrombosis remains a significant concern in the development and clinical use of ventricular assist devices (VADs). Traditional assessments of VAD thrombogenicity, primarily through animal studies, are costly and time-consuming, raise ethical concerns, and ultimately may not accurately reflect human outcomes. To address these limitations, we developed an aggressive in vitro testing protocol designed to provoke thrombosis and identify potential high-risk areas within the blood flow path. This protocol, motivated by the work of Maruyama et al., employs a modified anticoagulation strategy and utilizes readily available components, making it accessible to most laboratories conducting in vitro blood testing of VADs. We demonstrated the utility of this method through iterative testing and refinement of a miniature magnetically levitated pediatric VAD (PediaFlow PF5). The method has been effective in identifying thrombogenic hotspots caused by design and manufacturing flaws in early VAD prototypes, enabling targeted improvements before advancing to animal studies. Despite its limitations, including the absence of pulsatile flow and the influence of donor blood characteristics, this protocol serves as a practical tool for early-stage VAD development and risk mitigation.

Introduction

Ventricular assist devices (VADs) have become a standard of care in the management of patients with advanced heart failure, yet the risk of thrombosis and stroke remains a significant challenge1,2. Thrombosis within VADs is typically assessed during preclinical animal studies, which, while valuable, present substantial costs and logistical challenges. These studies are resource-intensive, time-consuming, and are susceptible to a single defect compromising the entire test and necessitating additional trials. This not only increases the financial burden but also raises ethical concerns due to the need for repeat....

Protocol

Ovine whole blood used in this study was obtained from a commercial vendor and, therefore, did not require a review by Cornell University's Institutional Animal Care and Use Committee.

1. Construction of the test flow loop

NOTE: See the Table of Materials for a detailed list of loop components and all other materials used in this protocol.

  1. Modify the intravenous (IV) bag.
    1. Use a plastic heat sealer to modify an IV bag to adjust its volume and shape, as depicted in Figure 1.
      NOTE: The shape of the bag facilitates de-....

Results

Successful execution of this protocol enables the identification of localized areas of platelet deposition, revealing problematic spots within the pump's flow path. Consistent application of this protocol allows for incremental improvements by addressing these identified "hotspots".

For example, during the development of the PediaFlow PF5 VAD, we encountered challenges in manually polishing the pressure side of the stator vanes due to the miniature size of the components. In vi.......

Discussion

First-in-human trial of a new pump is always a precarious endeavor, as preclinical studies cannot reliably predict the thrombogenicity of VADs in humans26. Notably, some VADs that demonstrated freedom from thrombosis in animal trials have later exhibited significant thrombogenicity in clinical use36. An aggressive in vitro testing regimen specifically designed to provoke thrombosis provides a valuable opportunity to identify potential design or manufacturing flaws .......

Disclosures

S.E.O. currently serves as a consultant for Magenta Medical and was previously a consultant at Boston Scientific. No other authors have any relevant financial disclosures or conflicts of interest to report.

Acknowledgements

This work was supported by the National Institutes of Health grant R01HL089456 and the U.S. Army Medical Research Acquisition Activity Project Number W81XWH2010387.

....

Materials

NameCompanyCatalog NumberComments
14-mL test tubesFalcon352059Round bottom polypropylene test tubes with snap-cap
1-way stopcockQosina99759Female Luer Lock, Male Luer with Spin Lock
3-way stopcockQosina997712 Female Luer Locks, Rotating Male Luer Lock
ACT+ cuvettes for HemochronWerfen000JACT+45/Box
All-purpose cleaner/degreaserSimple Green2710200613005Simple Green Cleaner and Degreaser. Use 1% solution.
Barbed connectorsQosina73311Material: polycarbonate; ¼” x ¼” straight connector
Barbed connectors w/ luer lockQosina73316Material: polycarbonate; ¼” x ¼” straight connector with luer lock
Bovine Serum Albumin (BSA)Thermo Scientific ChemicalsAAJ6465522Or equivalent
Calcium chloride, CaCl2Thermo Scientific ChemicalsAA89866-30Anhydrous, β‰₯96.0% ACS
Dissecting scope (recommended)Olympushttps://www.olympus-lifescience.com/en/technology/museum/micro/1984/Olympus SZH10 (continuous zoom magnification 7x - 70x) or similar
DPBS (w/o calcium and magnesium)Gibco14200075Dulbecco's phosphate-buffered saline, no calcium, no magnesium, 10X (must be diluted to 1X before use)
EDTAQuality Biological351-027-721EA0.5 M, pH 7.0–8.0 (Ethylenediaminetetraacetic acid)
Endoscope/borescope/otoscope camera (optional)Bebirdhttps://bebird.com/products/earsight-pro-ear-wax-removers3–4 mm probe diameter
Enzyme-active powdered detergentAlconox1304-1Alconox Tergazyme. Use 1% solution.
Extension Line, 30"QosinaΒ 3621830" length,Β  female luer lock to male luer lock
Extension Line, 6"QosinaΒ 362126" length,Β  female luer lock to male luer lock
Female luer lock, barbedQosina11548Fits 1/8 inch ID Tubing; material: polycarbonate;
Flow meterTransonichttps://www.transonic.com/t402-t403-consolesTransonic TS410 module
HemostatFisherbrand13-820-004Locking hemostat with at least 5 cm tip length
Heparin SodiumMcKesson Packaging Services9495131000 U/mL concentration
Hoffman clampHumboldtH8720Fine-threaded clamp
IV bag (compliant blood reservoir)Qosina51494Material: PVC, 2 Tube ports 0.258” ID. The 100-ml bag is modified using a heat sealer
Lint-free wipesKimberly-Clark Professional34120Kimtech Science Wipers
Magnetic stirrerINTLLABMS-500Or similar
Male luer lock, barbedQosina11549Fits 1/8 inch ID Tubing; material: polycarbonate;
Manometer (digital)Sper Scientific840081SPER-840081 or similar
Nylon filtering meshMcMaster-Carr9318T21100-ΞΌm (0.0039") opening size
Ovine bloodLampire7209004Donor whole blood, anticoagulated with ACD 14:86, shipped overnight
Plastic bag heat sealerUlineH-190Uline H-190 or similar (without cutter)
Silicone rubber adhesiveSmooth-OnΒ B00IRC1YI0Sil-Poxy or similar
Syringe w/ luer lock, 1 mLFisher Scientific14-955-646Fisherbrand manual syringe without needle for research purposes
Syringe w/ luer lock, 3 mLFisher Scientific14-955-457Fisherbrand manual syringe without needle for research purposes
Syringe w/ luer lock, 60 mLFisher Scientific14-955-461Fisherbrand manual syringe without needle for research purposes
Transfusion filterHaemonetics CorporationΒ SQ40S/SQ40NSHaemonetics Corporation SQ40S pall blood transfusion filter
TRIS Buffered SalineThermo Scientific ChemicalsAAJ62938K2TBS 10x (must be diluted to 1X before use), pH 7.4
TubingTygonADF00017Tygon ND-100-65 tubing (medical grade)
Ultrasonic flow sensorTransonichttps://www.transonic.com/hqxl-flowsensorsSelect appropriate flow sensor model for the tubing size used. ME6PXL clamp-on sensor fits the 3/8” OD tubing. The sensor is calibrated by Transonic for the test fluid (e.g., blood atΒ  24C) and tubing grade (e.g. Tygon ND-100-65)
Ultrasonic sonicator (optional)Branson UltrasonicsCPX952238RBranson CPX2800H or similar
VAD systemPediaFlowPF5The VAD system to be tested; includes the pump and the controller
Whole Blood Coagulation SystemWerfenhttps://www.werfen.com/na/en/point-of-care-testing-devices/ACT-machine-hemochron-signature-eliteHemochron Signature Elite or Signature Jr

References

  1. Kirklin, J. K., et al. Eighth annual INTERMACS report Special focus on framing the impact of adverse events. J Heart Lung Transplant. 36 (10), 1080-1086 (2017).
  2. Kormos, R. L., et al.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

In Vitro Thrombosis TestVentricular Assist DevicesThrombosis RiskThrombogenicity AssessmentAnimal StudiesTesting ProtocolAnticoagulation StrategyBlood Flow PathPediaFlow PF5Thrombogenic HotspotsDesign FlawsManufacturing Flaws

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright Β© 2025 MyJoVE Corporation. All rights reserved